![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 15/113 | |
A61K 31/713 | |||
A61P 3/06 | |||
A61P 9/00 | |||
A61P 43/00 |
(11) | Number of the document | 3578656 |
(13) | Kind of document | T |
(96) | European patent application number | 19168142.8 |
Date of filing the European patent application | 2007-05-10 | |
(97) | Date of publication of the European application | 2019-12-11 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
79945806 P | 2006-05-11 | US | |
81720306 P | 2006-06-27 | US | |
84008906 P | 2006-08-25 | US | |
82991406 P | 2006-10-18 | US | |
90113407 P | 2007-02-13 | US |
(72) |
TAN, Pamela, US
BRAMLAGE, Birgit, US
FRANK-KAMENETSKY, Maria, US
FITZGERALD, Kevin, US
AKINC, Akin, US
KOTELIANSKI, Victor E., US
|
(73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
(54) | COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE |
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE PCSK9 GENE |